[Antibiotic prophylaxis against bacterial infections in the hyposplenic and asplenic child]

Area of Science:

• Pediatric Infectious Diseases
• Hematology
• Surgical Outcomes

Background:

• Splenectomy significantly increases the risk of severe bacterial infections in children.
• Young children, particularly those under 2 years old and within 2 years post-splenectomy, are most vulnerable.
• Associated diseases and conditions like sickle cell anemia further elevate infection risk and mortality.

Purpose of the Study:

• To summarize the risks of infection in children following splenectomy.
• To outline current guidelines for antibiotic prophylaxis in asplenic and hyposplenic children.
• To emphasize the importance of early and long-term antibiotic use.

Main Methods:

• Review of observational cohort data on splenectomized patients.
• Analysis of historical study data (Holdsworth study, 1952-1987) on infection rates.
• Synthesis of current clinical guidelines for antibiotic prophylaxis.

Main Results:

• Postoperative infection rates in splenectomized children under 16 were 4.4%, with a 2.2% mortality rate.
• Severe bacterial infections are a leading cause of death in children with sickle cell anemia.
• Pneumococcal infections pose a significant threat due to frequent colonization in this age group.

Conclusions:

• Antibiotic prophylaxis, specifically daily oral Penicillin V (Oracilline), is essential for asplenic and hyposplenic children.
• Prophylaxis should commence at diagnosis for sickle cell anemia patients (around 2-3 months old).
• Duration of prophylaxis should extend at least 5 years post-splenectomy or up to age 15 for high-risk individuals.